News

company

year

domain

Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases

Repertoire® Immune Medicines 04.29.2024

Flagship Appoints Amy O’Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences

Invaio Sciences 04.08.2024

Flagship Pioneering Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2024

03.19.2024

Vesalius Therapeutics Announces Leadership Transition

Vesalius Therapeutics 03.07.2024

Dean Banks Appointed CEO of Indigo Ag and CEO-Partner of Flagship Pioneering

Indigo Agriculture 01.09.2024

Flagship Pioneering Announces New Origination Partners

01.08.2024

Flagship Pioneering Debuts Enabling Technologies Initiative

01.08.2024

Flagship Pioneering and Samsung Announce Collaboration to Advance Groundbreaking Technologies in Translational Science and Medicine

01.08.2024

Novo Nordisk Enters into Research Collaborations with Omega Therapeutics and Cellarity on Novel Treatment Approaches for Cardiometabolic Diseases

Cellarity, Omega Therapeutics 01.04.2024

Cellarity Announces the Expansion of Its Partnership with Novo Nordisk to Discover and Develop a Novel Treatment in Metabolic Steatohepatitis (MASH) Using Its Innovative Platform

Cellarity 01.04.2024

Loading